Anti-inflammatory effects induced by pharmaceutical substances on inflammatory active brain astrocytes—promising treatment of neuroinflammation (original) (raw)

Abstract

Background: Pharmaceutical treatment with probable anti-inflammatory substances that attack cells in various ways including receptors, ion channels, or transporter systems may slow down the progression of inflammatory conditions. Astrocytes and microglia are the most prominent target cells for inflammation in the central nervous system. Their responses upon inflammatory stimuli work through the NO/cyclic GMP/protein kinase G systems that can downregulate the ATP-induced Ca 2+ signaling, as well as G protein activities which alter Na + transporters including Na + /K +-ATPase pump activity, Toll-like receptor 4 (TLR4), glutamate-induced Ca 2+ signaling, and release of pro-inflammatory cytokines. The rationale for this project was to investigate a combination of pharmaceutical substances influencing the NO and the G i /G s activations of inflammatory reactive cells in order to make the cells return into a more physiological state. The ATP-evoked Ca 2+ signaling is important maybe due to increased ATP release and subsequent activation of purinergic receptors. A balance between intercellular Ca 2+ signaling through gap junctions and extracellular signaling mediated by extracellular ATP may be important for physiological function. Methods: Astrocytes in primary cultures were incubated with lipopolysaccharide in a physiological glucose concentration for 24 h to induce inflammatory reactivity. The probable anti-inflammatory substances sildenafil and 1α,25-Dihydroxyvitamin D3 together with endomorphin-1, naloxone, and levetiracetam, were used in the presence of high glucose concentration in the medium to restore the cells. Glutamate-, 5-HT-, and ATP-evoked intracellular Ca 2+ release, Na + /K +-ATPase expression, expression of inflammatory receptors, and release of tumor necrosis factor alpha were measured. Results: Sildenafil in ultralow concentration together with 1α,25-Dihydroxyvitamin D3 showed most prominent effects on the ATP-evoked intracellular Ca 2+ release. The μ-opioid agonist endomorphin-1, the μ-opioid antagonist naloxone in ultralow concentration, and the antiepileptic agent levetiracetam downregulated the glutamate-evoked intracellular Ca 2+ release and TLR4. The combination of the pharmaceutical substances in high glucose concentration downregulated the glutamate-and ATP-evoked Ca 2+ signaling and the TLR4 expression and upregulated the Na + /K +-ATPase pump.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (47)

  1. Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci. 2015;36:737-55.
  2. Rönnbäck C, Hansson E. Gap junction coupled cells, barriers and systemic inflammation. Int J Open Access Ophthalmol. 2017;2(1):7.
  3. Peixoto CA, Gomes FOS. The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review. J Inflammation. 2015;12:54. https://doi.org/ 10.1186/s12950-015-0099-7.
  4. Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci U S A. 1998;95:15735-40.
  5. Liu X, Gangoso E, Yi C, Jeanson T, Kandelman S, Mantz J, Giaume C. General anesthetics have differential inhibitory effects on gap junction channels and hemichannels in astrocytes and neurons. GLIA. 2016;64:524-36. https://doi. org/10.1002/glia.22946 Epub 2015 Dec 15.
  6. Okamoto T, Suzuki K. The role of gap junction-mediated endothelial cell-cell interaction in the crosstalk between inflammation and blood coagulation. Int J Mol Sci. 2017;18:2254. https://doi.org/10.3390/ijms18112254.
  7. Strokin M, Sergeeva M, Reiser G. Proinflammatory treatment of astrocytes with lipopolysaccharide results in augmented Ca 2+ signaling through increased expression of VIA phospholipase A2 (iPLA2). Am J Physiol Cell Physiol. 2011;300:C542-9.
  8. Forshammar J, Block L, Lundborg C, Biber B, Hansson E. Naloxone and ouabain in ultra-low concentrations restore Na + /K + -ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes. J Biol Chem. 2011;286: 31586-97.
  9. Hansson E. Long-term pain, neuroinflammation and glial activation. Scand J Pain. 2010;1:67-72.
  10. Hansson E. Actin filament reorganization in astrocyte networks is a key functional step in neuroinflammation resulting in persistent pain -novel findings on network restoration. Neurochem Res. 2015;40:372-9. https://doi. org/10.1007/s11064-014-1363-6.
  11. Gérard F, Hansson E. Inflammatory activation enhances NMDA-triggered Ca 2 + signaling and IL-1β secretion in primary cultures of rat astrocytes. Brain Res. 2012;1473:1-8.
  12. Shim S, Shuman M, Duncan E. An emerging role of cGMP in the treatment of schizophrenia: a review. Schozphrenia Res. 2016;170:226-31.
  13. Rapôso C, Luna RLA, Nunes AKS, Thomé R, Peixoto CA. Role of iNOS-NO- cGMP signaling in modulation of inflammatory and myelination processes. Brain Res Bull. 2014;104:60-73.
  14. Peixoto CA, Nunes AKS, Garcia-Osta A. Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition. Med Inf 20152015; ID940207,https://doi. org/10.1155/2015/940207.
  15. Rotella DP. Phosphodiesterase 5 inhibitors: current status and potential applications. Nature. 2012;1:674-84.
  16. Zhao L. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity. Circulation. 2002; 107:234-7.
  17. Bollen E, Prickaerts J. Phosphodiesterases in neurodegenerative disorders. IUBMB Lif. 2012;64:965-70.
  18. Puzzo D, Sapienza S, Arancio O, Palmeri A. Role of phosphodiesterase 5 in synaptic plasticity and memory. Neuropsychatric Dis Treat. 2008;4:371-87.
  19. Nunes AKS, Rapôso C, Björklund U, Cruz-Höfling MA, Peixoto CA, Hansson E. Sildenafil (Viagra) prevents and restores LPS-induced inflammation in astrocytes. Neurosci Lett. 2016;630:59-65.
  20. Haghikia A, Ladage K, Hinkerohe D, Vollmar P, Heupel K, Dermietzel R, Faustmann PM. Implications of anti-inflammatory properties of the anticonvulsant drug levetircatam in astrocytes. J Neurosci Res. 2008;86: 1781-8.
  21. Block L, Björklund U, Westerlund A, Jörneberg P, Biber B, Hansson E. A new concept affecting restoration of inflammation-reactive astrocytes. Neuroscience. 2013;250:536-45.
  22. Enkhjargal B, McBridem DW, Manaenkom A, Reism C, Sakaim Y, Tang J, Zhang J. Intranasal administration of vitamin D attenuates blood-brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats. J Cereb Blood Flow Metab. 2017;37:2555-66. https://doi. org/10.1177/027 678X 667 47.
  23. Jo WK, Zhang Y, Emrich HM, Dietrich DE. Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci. 2015;
  24. https://doi.org/10.3389/fncel.2015.00268.
  25. Adamczak DM. The role of toll-like receptors and vitamin D in cardiovascular diseases -a review. Int J Molec Sci. 2017;18:2252. https://doi.org/10.3390/ ijms18112252.
  26. Rotter Sopasakis V, Wickelgren R, Sukonina V, Brantsing C, Svala E, Hansson E, Enerbäck S, Lindahl A, Skiöldebrand E. Elevated glucose levels preserve glucose uptake, hyaluronan production and low glutamate release following IL-1β stimulation of differentiated chondrocytes. Cartilage 2018;
  27. Hansson E, Werner T, Björklund U, Skiöldebrand E. Therapeutic innovation: inflammatory-reactive astrocytes as targets of inflammation. IBRO Rep. 2016;1:1-9.
  28. Berridge MJ. Inositol trisphosphate and calcium oscillations. Biochem Soc Symp. 2007;74:1-7.
  29. Persson M, Brantefjord M, Hansson E, Rönnbäck L. Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-α. GLIA. 2005;51:111-20.
  30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
  31. Giaume C, Liu X. From a glial syncytium to a more restricted and specific glial networking. J Physiol. 2012;106:34-9.
  32. Hansson E, Skiöldebrand E. Coupled cell networks are target cells of inflammation, which can spread between different body organs and develop into systemic chronic inflammation. J Inflammation. 2015;12:44. https://doi.org/10.1186/s12950-015-0091-2.
  33. Rothhammer V, Quintana FJ. Control of autoimmune CNS inflammation by astrocytes. Semin Immunopathol. 2015;37:625-38. https://doi.org/10.1007/ s00281-015-0515-3.
  34. Block L, Lundborg C, Bjersing J, Dahm P, Hansson E, Biber B. Ultralow dose of naloxone as an adjuvant to intrathecal morphine infusion improves perceived quality of sleep but fails to alter persistent pain. A randomized, double-blind, controlled study. Clin J Pain. 2015. [Epub ahead of print]. https://doi.org/10.1097/AJP.0000000000000200.
  35. Hertz L, Xu J, Song D, Du T, Li B, Yan E, Peng L. Astrocytic glycogenolysis: mechanisms and functions. Metab Brain Dis. 2015;30:317-33.
  36. Loaiza A, Porras OH, Barros LF. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci. 2003;13:7337-42.
  37. Verkhratsky A, Rodríguez JJ, Parpura V. Calcium signaling in astroglia. Mol Cell Endocrin. 2012;353:45-56.
  38. Bernardinelli Y, Magistretti PJ, Chatton J-Y. Astrocytes generate Na + - mediated metabolic waves. Proc Natl Acad Sci U S A. 2004;101:14937-42.
  39. Jurcovicova J. Glucose transport in brain -effect of inflammation. End Regul. 2014;48:35-48. https://doi.org/10.4149/endo\_2014\_01\_35.
  40. Cotrina ML, Lin JH-C, López-García JC, Naus CCG, Nedergaard M. ATP- mediated glia signaling. J Neurosci. 2000;20:2835-44.
  41. Vardjan N, Zorec R. Excitable astrocytes: Ca 2+ -and cAMP-regulated exocytosis. Neurochem Res. 2015;40:2414-24.
  42. Beamer E, Kovács G, Sperlágh B. ATP released from astrocytes modulates action potential threshold and spontaneous excitatory postsynaptic currents in the neonatal rat prefrontal cortex. Brain Res Bull. 2017;135:129-42.
  43. Zhao S, Zhang L, Lian G, Wang X, Zhang H, Yao X, Yang J, Wu C. Sildenafil attenuates LPS-induced pro-inflammatory responses through down- regulation of intracellular ROS-related MAPK/NF-қB signaling pathways in N9 microglia. Int Immunopharmacol. 2011;11:468-74.
  44. O'Neill HM. AMPK and exercise: glucose uptake and insulin sensitivity. Diab Metab. 2013;37:1-21.
  45. Nunes AKS, Rapôso C, Rocha SWS, de Sousa Barbosa KP, de Almeidam RL, da Cruz-Höfling MA, Peixoto CA. Involvement of AMP, IKβα-NFқB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model. Brain Res. 2015;162:119-33.
  46. Borán MS, Garcia A. The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes. J Neurochem. 2007;102:216-30.
  47. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh J-C, Jurutka PW. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92: 77-98. https://doi.org/10.1007/s00223-012-9619-0.